Evaluation of Residual Disease and TKI Duration Are Critical Predictive Factors for Molecular Recurrence after Stopping Imatinib First-line in Chronic Phase CML Patients

Document type :
Journal articles
Complete list of metadatas

https://hal.archives-ouvertes.fr/hal-02374871
Contributor : Dominique Chadeyron <>
Submitted on : Thursday, November 21, 2019 - 5:08:12 PM
Last modification on : Friday, November 22, 2019 - 1:38:23 AM

Identifiers

Collections

Citation

Franck Emmanuel Nicolini, Stéphanie Dulucq, Lisa Boureau, Pascale Cony-Makhoul, Aude Charbonnier, et al.. Evaluation of Residual Disease and TKI Duration Are Critical Predictive Factors for Molecular Recurrence after Stopping Imatinib First-line in Chronic Phase CML Patients. Clinical Cancer Research, American Association for Cancer Research, 2019, 25 (22), pp.6606-6613. ⟨10.1158/1078-0432.CCR-18-3373⟩. ⟨hal-02374871⟩

Share

Metrics

Record views

19